We maintain our Neutral recommendation on Edwards Lifesciences Corporation (NYSE:EW), a leading player in heart valves and hemodynamic monitoring.
Edwards is one of the leading players in the field of heart valve therapy which accounts for approximately 61% of its total revenues. Contribution from this segment has increased steadily over the past, from 47% in 2007 to 54% in 2009.
The company has a strong product portfolio with many launched only in the recent past. Increased acceptance of these … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards